These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2125426)

  • 1. [Chronic gastric ulcer in a child with Glanzmann thrombasthenia. Usefulness of prostaglandin E2].
    Calva-Rodríguez R; Mejía-Domínguez AM; Pandzich-Arapov S
    Bol Med Hosp Infant Mex; 1990 Sep; 47(9):653-5. PubMed ID: 2125426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of prostanoids in the treatment of gastric ulcer.
    Rachmilewitz D
    Clin Invest Med; 1987 May; 10(3):238-42. PubMed ID: 3113800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Stomach ulcer healing with enprostil, an orally effective prostaglandin E2 analog: direct comparative study with ranitidine].
    Hüttemann W; Beckenbach HP; Daake H; Dammann HG; Jancke T; Kalek HD; Kühn V; Martens W; Müller P; Rohner HG
    Z Gastroenterol; 1986 May; 24(5):252-6. PubMed ID: 3088859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gastroduodenal ulcer pathology and prostaglandins].
    Bellanger J; Pointereau-Bellanger A
    Ann Gastroenterol Hepatol (Paris); 1987 May; 23(3):129-34. PubMed ID: 3113323
    [No Abstract]   [Full Text] [Related]  

  • 5. Enprostil, a prostaglandin E2 analogue, in the treatment of gastric ulcer--a multicentre comparison with pirenzepine.
    Reed PI; Jazrawi RP; Northfield TC; Carr-Locke D; Mountford RA; Williams JG; Schiller KF; English JR
    Br J Clin Pract; 1990 Feb; 44(2):48-51. PubMed ID: 2116819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Enprostil versus cimetidine in the treatment of benign gastric ulcer].
    Segovia E; Barrinagarrementería R; de la Torre Bravo A
    Rev Gastroenterol Mex; 1987; 52(2):99-102. PubMed ID: 3114860
    [No Abstract]   [Full Text] [Related]  

  • 7. The therapeutic efficacy of misoprostol in peptic ulcer disease.
    Watkinson G; Hopkins A; Akbar FA
    Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of two new therapies for peptic ulcer disease: omeprazole and the prostaglandin analogues.
    McColl KE
    Dig Dis; 1988; 6(2):65-75. PubMed ID: 3129220
    [No Abstract]   [Full Text] [Related]  

  • 9. Peptic ulcer disease, cytoprotection, and prostaglandins.
    Fiske SC
    Arch Intern Med; 1988 Oct; 148(10):2112-3. PubMed ID: 3140751
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug therapy of peptic ulcer. What is coming up?].
    Müller P; Dammann HG; Simon B; Kommerell B
    Leber Magen Darm; 1987 Feb; 17(1):50-4. PubMed ID: 3104707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy and prevention of peptic lesions by prostaglandins].
    Müller P; Dammann HG; Simon B
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():166-74. PubMed ID: 3116777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Enprostil in the acute treatment of duodenal ulcer: direct comparative study with pirenzepin].
    Rohner HG; Beckenbach HP; Daake H; Dammann HG; Hüttemann R; Kalek S; Kühn V; Müller P; Simon B
    Z Gastroenterol; 1986 May; 24(5):257-61. PubMed ID: 3088860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats.
    Schmassmann A; Peskar BM; Stettler C; Netzer P; Stroff T; Flogerzi B; Halter F
    Br J Pharmacol; 1998 Mar; 123(5):795-804. PubMed ID: 9535006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological management of patients with peptic ulcer disease: prospects for the late 1980's.
    Thomson AB; Mahachai V
    Clin Invest Med; 1987 May; 10(3):152-70. PubMed ID: 2887321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enprostil. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease.
    Goa KL; Monk JP
    Drugs; 1987 Nov; 34(5):539-59. PubMed ID: 3121276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ulcer healing and relapse rates after initial treatment with cimetidine or sucralfate.
    Marks IN; Lucke W; Wright JP; Girdwood AH
    J Clin Gastroenterol; 1981; 3(Suppl 2):163-5. PubMed ID: 7033353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoprotection of gastroduodenal mucous membrane with analogues of prostaglandins.
    Lauritsen K; Laursen LS; Rask-Madsen J
    Recenti Prog Med; 1989 Jun; 80(6):344-52. PubMed ID: 2672199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative clinical trial of enprostil and ranitidine in the treatment of gastric ulcer.
    Dammann HG; Hüttemann W; Kalek HD; Rohner HG; Simon B
    Am J Med; 1986 Aug; 81(2A):80-4. PubMed ID: 3092661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of some naturally occurring prostaglandins and synthetic analogues on gastric secretion and ulcer healing in man.
    Karim SM; Fung WP
    Adv Prostaglandin Thromboxane Res; 1976; 2():529-39. PubMed ID: 790914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of sucralfate and cimetidine in the treatment of duodenal and gastric ulcers. A multicenter study.
    Pop P; Nikkels RE; Thys O; Dorrestein GC
    Scand J Gastroenterol Suppl; 1983; 83():43-7. PubMed ID: 6356320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.